Hepatitis B screening: Who to target? A French sexually transmitted infection clinic experience

Journal of Hepatology

Volumn 58, Issue 4, 2013, Pages 690-697

  Spenatto, N ^a   Boulinguez, S ^a   Mularczyk, M ^a   Molinier, L ^a   Bureau, C ^a   Saune, K ^a   Viraben, R ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Hepatitis B; Risk factors; Sexually transmitted disease; Targeting screening

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPLOYMENT; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SCREENING; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VACCINATION;

ADULT; CARRIER STATE; ENDEMIC DISEASES; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT CLINICS, HOSPITAL; RISK FACTORS; RISK-TAKING; UNEMPLOYMENT; YOUNG ADULT;

EID: 84880950236     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.044     Document Type: Article

References (30)

1. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2004 97 107 (Pubitemid 38365759)
2. Institut de veille sanitaire. Estimated prevalence of anti-HCV and markers of hepatitis B among the insured of the general metropolitan France, 2003-2004. Descriptive analysis, in January 2005. Available at < http://www.invs.sante.fr/publications/2005/analyse-descriptive-140205/ rapport-analyse-descriptive.pdf > [accessed 27.07.11].
3. D. Antona, E. Couturier, and C. Larsen Epidemiology of viral hepatitis in France Rev Prat 61 2011 25 27
4. F. Cazein, S. Levu, and J. Pillonel HIV testing activity in France, 2003-2009 BEH 45-46 2010 451 454
5. Haute Autorité de Santé. Stratégies de dépistage biologique des hépatites B et C, < http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/ strategies-de-depistage-biologique-des-hepatites-virales-b-et-c-synthese.pdf > [accessed 27.07.2011].
6. M.L. Gutiérrez-García, C.M. Fernandez-Rodriguez, J.L. Lledo-Navarro, and I. Buhigas-Garcia Prevalence of occult hepatitis B virus infection World J Gastroenterol 17 12 2011 1538 1542
7. S. Ocana, M.L. Casas, I. Buhigas, and J.L. Lledo Diagnostic strategy for occult hepatitis B virus infection World J Gastroenterol 17 12 2011 1553 1557
8. World Health Organization. WHO/CDS/CSR/LYO/2002.2: hepatitis B. Available at: < http://www.who.int/emc > [accessed 27.07.11].
9. J. Gaudelus Immunization against hepatitis B virus in France Rev Prat 60 2010 1373 1376
10. F. Denis, and D. Levy-Bruhl Mass vaccination against hepatitis B: the French example Curr Top Microbiol Immunol 304 2006 115 129 (Pubitemid 47413306)
11. C. Meffre, Y. Le Strat, and E. Delarocque-Astagneau Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors J Med Virol 82 2010 546 555
12. T. Marschall, M. Kretzschmar, M.J. Mangen, and S. Shalm High impact of migration on the prevalence of chronic hepatitis B in The Netherlands Eur J Gastroenterol Hepatol 20 2008 1214 1225
13. I.K. Veldhuizjen, L.J. Smits, and M.J. van de Laar The importance of imported infections in maintaining hepatitis B in The Netherlands Epidemiol Infect 133 2005 113 119 (Pubitemid 40276981)
14. M. Toy, I.K. Veldhuizjen, M.C. Mostert, R.A. de Man, and J.H. Richardus Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands J Med Virol 80 2008 399 404 (Pubitemid 351206887)
15. T. Wormann, L. Prufer-Kramer, and A. Kramer Serological and sociodemographic differences in HBV-patients with and without migration background Z Gastroenterol 48 2010 533 541
16. C.E. Turnour, M.A. Cretikos, and S.J. Conaty Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data Aust N Z J Public Health 35 2011 22 26
17. G. Uddin, D. Shoeb, and S. Solaiman Prevalence of chronic viral hepatitis in people of South Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin J Viral Hepat 17 2010 327 335
18. Y.J. van der Veen, O. de Zwart, H.A. Voeten, J.P. Mackenbach, and J.H. Richardus Hepatitis B screening in the Turkish-Dutch population in Rotterdam, The Netherlands; qualitative assessment of socio-cultural determinants BMC Public Health 9 2009 328
19. S. Hahne, M. Ramsay, K. Balogun, W.J. Edmunds, and P. Mortimer Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy J Clin Virol 29 2004 211 220 (Pubitemid 38281210)
20. M.I. Andersson, N. Low, and C.J. Irish Investigation of a large community-based outbreak of hepatitis B infection in the United Kingdom Epidemiol Infect 16 2011 1 11
21. M. Segura, C.T. Bautista, and R. Marone HIV/STI co-infections, syphilis incidence, and hepatitis B vaccination: the Buenos Aires cohort of men who have sex with men AIDS Care 22 2010 1459 1465
22. A. Mele, M.E. Tosti, and A. Mariano Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges Clin Infect Dis 46 2008 868 875 (Pubitemid 351417188)
23. O. Adekanle, D.A. Ndububa, O.O. Ayodeji, B. Paul-Odo, and T.A. Folorunso Sexual transmission of the hepatitis B virus among blood donors in a tertiary hospital in Nigeria Singapore Med J 51 2010 944 947
24. G. Rimseliene, O. Nilsen, H. Klovstad, H. Blystad, and P. Aavitsland Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009 BMC Infect Dis 11 2011 153
25. R.J. Gilson, A. de Ruiter, J. Waite, and E. Ross Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage Sex Transm Infect 74 1998 110 115 (Pubitemid 28225823)
26. L. Topp, C. Day, G.J. Dore, and L. Maher Poor criterion validity of self reported hepatitis B infection and vaccination status among injecting drug users: a review Drug Alcohol Rev 28 2009 669 675
27. K.H. Herbinger, H.D. Nothdurft, and R. Prymula Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries Curr Med Res Opin 27 2011 489 496
28. L.Y. Hwang, J.R. Kramer, and C. Troisi Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population Hepatology 44 2006 341 351 (Pubitemid 44214873)
29. A. Nishioka Sde, T.W. Gyorkos, L. Joseph, J.P. Collet, and J.D. Maclean Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed Epidemiol Infect 128 2002 63 71 (Pubitemid 34211205)
30. P.K. Nelson, B.M. Mathers, and B. Cowie Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews Lancet 378 2011 571 583